Ansun Biopharma, Inc. Email Format

Biotechnology ResearchCalifornia, United States11-50 Employees

Ansun Biopharma, Inc. is a biotechnology research company based in San Diego, California, focused on late-stage clinical development of first-in-class biologics. Its lead product, DAS181, is a multi-function sialidase fusion protein intended to protect host cells during respiratory virus infections, including parainfluenza, influenza, and COVID-19. The company concentrates on therapies for vulnerable patient populations and seeks to advance its sialidase platform across additional indications. In addition to antiviral programs, Ansun is pursuing oncology and autoimmune disease efforts built on this technology base.

The firm operates as a small to mid-sized entity within the biotechnology sector. Its work centers on leveraging the sialidase platform to address serious diseases, spanning respiratory viral infections and selected oncology and autoimmune disease programs.

Sign up for free to view info

Company overview Employee directory